0001554907-14-000002.txt : 20141113 0001554907-14-000002.hdr.sgml : 20141113 20141113130358 ACCESSION NUMBER: 0001554907-14-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141113 DATE AS OF CHANGE: 20141113 EFFECTIVENESS DATE: 20141113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tolero Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001554907 IRS NUMBER: 452693385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-223152 FILM NUMBER: 141217364 BUSINESS ADDRESS: STREET 1: 9980 SOUTH 300 WEST SUITE # 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-285-7570 MAIL ADDRESS: STREET 1: 9980 SOUTH 300 WEST SUITE # 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84070 D/A 1 primary_doc.xml X0707 D/A LIVE 0001554907 Tolero Pharmaceuticals, Inc. 2975 Executive Parkway Suite 320 Lehi UT UTAH 84043 801-285-6003 DELAWARE None None Corporation true 2011 David Bearss, Ph.D. c/o Tolero Pharmaceuticals, Inc. 2975 Executive Parkway, Suite 320 Lehi UT UTAH 84043 Executive Officer Director Promoter Dallin Anderson c/o Tolero Pharmaceuticals, Inc. 2975 Executive Parkway, Suite 320 Lehi UT UTAH 84043 Executive Officer Director Promoter Pharmaceuticals Decline to Disclose 06b true 0001554907-14-000001 2014-08-04 false true true false 0 T.R. Winston & Company, LLC 10571 T.R. Winston & Company, LLC 10571 1999 Avenue of the Starts 25th Floor Los Angeles CA CALIFORNIA 90067 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA WI WISCONSIN false 35469236 21861077 13608159 $16,072,970.64 new money; $5,318,870.85 conversion of convertible promissory notes (principal and accrued interest); $469,236.07 warrants to purchase common stock false 44 0 1395067 0 false Tolero Pharmaceuticals, Inc. /s/ Dallin Anderson Dallin Anderson President 2014-11-12